Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,341,800 | 875,300 | 240,500 | 1,632,200 | 1,365,500 |
| Depreciation Amortization | 748,600 | 484,900 | 234,600 | 963,400 | 694,500 |
| Income taxes - deferred | 194,700 | -59,100 | -27,800 | -158,100 | -99,700 |
| Accounts receivable | 74,900 | -170,500 | -181,000 | 222,300 | 127,600 |
| Other Working Capital | -948,900 | -1,123,100 | -333,500 | -155,200 | -183,500 |
| Other Operating Activity | 281,600 | 412,700 | 326,500 | 370,900 | 210,200 |
| Operating Cash Flow | $1,692,700 | $420,200 | $259,300 | $2,875,500 | $2,114,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -109,900 | -63,700 | -37,100 | -153,700 | -114,400 |
| Net Acquisitions | N/A | N/A | N/A | -1,074,800 | -668,000 |
| Purchase Of Investment | -91,000 | N/A | N/A | N/A | 0 |
| Sale Of Investment | 56,600 | 0 | N/A | 551,500 | 96,700 |
| Purchase Sale Intangibles | -15,300 | -10,000 | -10,000 | -206,100 | -179,100 |
| Other Investing Activity | 4,900 | -40,600 | -10,200 | -122,200 | -94,900 |
| Investing Cash Flow | $-139,400 | $-104,300 | $-47,300 | $-799,200 | $-780,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,733,100 | 1,733,400 | N/A | N/A | 0 |
| Debt Repayment | -1,750,000 | -1,750,000 | N/A | -650,000 | -650,000 |
| Other Financing Activity | -148,000 | -18,100 | -23,000 | -33,500 | -41,400 |
| Financing Cash Flow | $-164,900 | $-34,700 | $-23,000 | $-683,500 | $-691,400 |
| Exchange Rate Effect | 99,400 | 102,600 | 34,300 | -67,700 | 6,700 |
| Beginning Cash Position | 2,375,000 | 2,375,000 | 2,375,000 | 1,049,900 | 1,049,900 |
| End Cash Position | 3,862,800 | 2,758,800 | 2,598,300 | 2,375,000 | 1,699,200 |
| Net Cash Flow | $1,487,800 | $383,800 | $223,300 | $1,325,100 | $649,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,692,700 | 420,200 | 259,300 | 2,875,500 | 2,114,600 |
| Capital Expenditure | -109,900 | -63,700 | -37,100 | -153,700 | -114,400 |
| Free Cash Flow | 1,582,800 | 356,500 | 222,200 | 2,721,800 | 2,000,200 |